UCB
Biotechnology / Pharmaceuticals
UCB.BR
€ 73 (0.79)%
Share price
$ 15 bn
Market Cap
$ 18 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
UCB aims to achieve net zero for Scope 1 + 2 by 2030
This target has not been verified as science based according to SBTi
Secondary Climate Goal
UCB aims to reduce all Scopes by 38% by 2030 from a base year 2015
<2°C
GHG emissions and Carbon intensity
UCB reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 46 Kt (-2.5 /-5.2% y-o-y). Also positively, carbon intensity declined to 7.1 t (-1.1 /-13.4% y-o-y).
UCB's Scope 3 emissions decreased to 34 Kt (
The company is committed to achieving net zero for Scope 1 + 2 by 2030, which translates into the estimated reduction of -5.1 Kt per annum over the period of FY2022 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.
Copyright © 2023 Exerica. All rights reserved.